Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
University Hospital Birmingham
View at source ↗Clinical trial
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Brief summary
RATIONALE: Studying different factors that effect patients with newly diagnosed bladder cancer may help doctors learn more about the disease, improve the ability to plan cancer treatment, and help patients live more comfortably. PURPOSE: This clinical trial is studying different factors affecting patients with newly diagnosed bladder cancer.
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Trial details
- status
- UNKNOWN
- phase
- PHASE3
- study type
- INTERVENTIONAL
- enrollment
- 3400
- sponsor
- University Hospital Birmingham
- conditions
- Bladder Cancer
- interventions
- DRUG: selenium; DRUG: vitamin E; PROCEDURE: biopsy; PROCEDURE: chemoprevention; PROCEDURE: cryopreservation; PROCEDURE: cytology specimen collection procedure; PROCEDURE: diagnostic procedure; PROCEDURE: gene expression analysis; PROCEDURE: immunohistochemistry staining method; PROCEDURE: laboratory biomarker analysis
- start date
- 2005-12-01
- has results
- false
- data source
- ClinicalTrials.gov
- data processed
- 2026-10-29T09:00:05
- modifications
- selected fields only; whitespace normalized; brief summary truncated to 2,000 characters
Record
- Archive ID
- nct:NCT00553124
- Published
- Nov 5, 2007
- Updated
- Jan 10, 2014
- Venue
- ClinicalTrials.gov
- ClinicalTrials.gov
- NCT00553124
- Categories
- Bladder Cancer
- License
- ClinicalTrials.gov terms (attribution, processing date, modifications noted)
- Provenance
- clinicaltrials